Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141939 |
| CAS No | NA |
| Mol.F. | C19H20N6O3 |
| Mol.Wt. | 380.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141940 |
| CAS No | NA |
| Mol.F. | C26H32N6O5 |
| Mol.Wt. | 508.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141941 |
| CAS No | NA |
| Mol.F. | C29H30N8O6 |
| Mol.Wt. | 586.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141942 |
| CAS No | NA |
| Mol.F. | C30H32N8O6 |
| Mol.Wt. | 600.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141943 |
| CAS No | NA |
| Mol.F. | C17H19N5O4 |
| Mol.Wt. | 357.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141944 |
| CAS No | NA |
| Mol.F. | C8H9N3O3 |
| Mol.Wt. | 195.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141945 |
| CAS No | NA |
| Mol.F. | C8H7N3O5 |
| Mol.Wt. | 225.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141946 |
| CAS No | NA |
| Mol.F. | C27H26N8O6 |
| Mol.Wt. | 558.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141947 |
| CAS No | NA |
| Mol.F. | C29H31N7O5 |
| Mol.Wt. | 557.6 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141948 |
| CAS No | NA |
| Mol.F. | C27H27N7O5 |
| Mol.Wt. | 529.6 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141949 |
| CAS No | NA |
| Mol.F. | C27H27N7O5 |
| Mol.Wt. | 529.6 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141950 |
| CAS No | NA |
| Mol.F. | C27H28N8O4 |
| Mol.Wt. | 528.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141951 |
| CAS No | NA |
| Mol.F. | C20H20F2N4O7 |
| Mol.Wt. | 466.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141952 |
| CAS No | NA |
| Mol.F. | C20H20F2N4O7 |
| Mol.Wt. | 466.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141953 |
| CAS No | NA |
| Mol.F. | C24H30N2O4 |
| Mol.Wt. | 410.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141954 |
| CAS No | NA |
| Mol.F. | C13H18N6O2 |
| Mol.Wt. | 290.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |